Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
21.50
+0.40 (1.90%)
At close: Jul 21, 2026, 4:00 PM EDT
21.50
0.00 (0.00%)
After-hours: Jul 21, 2026, 4:50 PM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Alignment Healthcare stock has a consensus rating of "Strong Buy" and an average price target of $24.92. The average 1-year stock price forecast is 15.91% higher than the current stock price, while the lowest is $16 (-25.58%) and the highest is $30 (+39.53%).
Price Target: $24.92 (+15.91%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alignment Healthcare stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 10 | 10 | 10 | 10 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Scott Fidel Goldman Sachs | Goldman Sachs | Buy Maintains $25 | Buy | Maintains | $25 | +16.28% | Jul 10, 2026 |
| Raymond James | Raymond James | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 9, 2026 |
| UBS | UBS | Hold Maintains $22 | Hold | Maintains | $22 | +2.33% | Jul 8, 2026 |
| KeyBanc | KeyBanc | Buy Maintains $28 | Buy | Maintains | $28 | +30.23% | Jun 10, 2026 |
| Barclays | Barclays | Hold Maintains $19 → $16 | Hold | Maintains | $19 → $16 | -25.58% | May 26, 2026 |
Financial Forecast
Revenue This Year
5.19B
from 3.95B
Increased by 31.41%
Revenue Next Year
6.51B
from 5.19B
Increased by 25.46%
EPS This Year
0.48
from 0.32
Increased by 47.78%
EPS Next Year
0.72
from 0.48
Increased by 52.11%
EPS and Forward PE are based on non-GAAP adjusted numbers.